No, he's just being a jerk, pointing to other TSE stocks that continue to do well as rebuttal to the point that JDX will do much better when it moves to the NASDAQ. The fact that he's comparing companies with different businesses, different fundamentals, different finances, different management and different strategies underlines the fact his logic is spurious, of course. He could equally have tried to make the same fallacious point by using companies like BIDS that moved to the NASDAQ but are now trading lower; the logic, the connection, is just as silly.
Undoubtedly JDX will do better when it has more US attention. More, it will do better when the name change is announced, the Medsite IPO is happening, and the promo ball starts rolling.
Leave fuddle to his CN.B...which is still as of this point NOT being taken out by competitors in spite of its dramatically low price. Will it happen? Undoubtedly. At a premium? Maybe, maybe. In the meantime, do the CN.B threads have to put up with constant needling from people who have no interest in the stock? Hope nobody is subjecting them to fuddle's treatment of this thread.
WUWT |
